Patent · US Active

Certain protein kinase inhibitors

US10087195B2 · kind B2 · utility

1Cited by

0References

14Claims

0Family size

Assignees

Inventors

Weibo Wang · Moraga, US
Xingdong Zhao · Chongqing, CN
Tongshuang Li · Surrey, CA
Qiang Tian · Sichuan, CN
Huajie Zhang · Shanghai, CN
Haohan TAN · Chongqing, CN
Xianlong Wang · Chongqing, CN
Qihong LIU · Chongqing, CN
Zhifu Li · 红钢城街道, CN
Weipeng ZHANG · Chongqing, CN
Zhifang Chen · Tangxia, CN
Lihua Jiang · Beijing, CN
Yanxin Liu · Chongqing, CN
Li Linghu · Chongqing, CN
Min Lin · Chongqing, CN
Jing Sun · Suzhou, CN

Key dates

Filing date	May 27, 2015
Grant date	Oct 2, 2018
Priority date	—
Expiry date	May 27, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D495/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are compound of formula (I) as certain CDK4/6 inhibitors, pharmaceutical compositions thereof, and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.